1Clinique Cardiologique de I'Hôpital Necker, Paris.
Calcium channel blockers, particularly verapamil, show promise in secondary prevention after myocardial infarction for specific patient groups. These drugs are a viable alternative when beta-blockers are contraindicated, especially in patients with respiratory issues.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: